Spain's Farmadosis sells stake to Miura Partners to fund global expansion
What's the deal? Spanish pharmacy-automation specialist Farmadosis has sold a stake to Miura PartnersDealroom has a profile for this one. Try Dealroom →, through its Miura Impact Fund, to fund a new growth phase. Founder Asier Zubillaga stays on in an executive role focused on business and product, while Joaquín González remains chief executive officer. The investment amount and stake were not disclosed.
What does Farmadosis do? Founded in 2012 and based in Mallorca, it makes automated systems for preparing and managing medication, combining hardware, software, consumables, and technical service built on its own technology. Its roughly 50 staff, mostly technicians and engineers, serve pharmacies, hospitals, and care homes across more than 25 countries in Europe, Latin America, and the Middle East.
By the numbers: Farmadosis reports around €15 million in revenue and says it has grown at a sustained double-digit pace in recent years. It calls itself the Spanish market leader in personalised dosage systems.
What's the endgame? Miura will back Farmadosis to accelerate international expansion and reinforce both organic and acquisitive growth. The firm plans to explore acquisitions that broaden its services and strengthen its presence in strategic markets.
Why now? The deal follows a 2026 agreement with Korean automation maker Cretem to distribute its products exclusively across Europe — a route to widen Farmadosis's offering beyond its own technology. The company was also named small business of the year in the Balearic Islands.
"The entry of Miura Partners is an important step for Farmadosis and will allow us to tackle a new phase of growth," Zubillaga said (translated from Spanish). Miura partner Guillem Augé said the firm was "very pleased to partner with the Farmadosis team."
The signal: Miura's impact fund is betting on medication automation as an ageing population, a growing number of chronically ill patients, and shortages of nursing and pharmacy staff strain health systems. Automating manual dose preparation promises to cut errors and improve traceability — but the undisclosed terms make the deal's financial scale hard to gauge.
Read more: capital-riesgo.es
Image credit: NavyMedicine
